Showing results (71-80 of 168) with videos related to
Sort By:
Pageof 17
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 25, 2006
[Flecainide controlled-release for prevention of atrial fibrillation relapse]T Simon, M Mary-Krause, A Chatelin, et al.Journal of Cardiovascular Pharmacology|May 1, 1981
Cardiac electrophysiologic effects of quinidine and propranolol isomers in anesthetized dogs: concentration-response relationshipsP Jaillon, J Heckle, J P Aubry, et al.Clinical Pharmacology and Therapeutics|July 1, 1980
Intravenous N-acetylprocainamide disposition kinetics in coronary artery diseaseR E Kates, P Jaillon, D S Rubenson, et al.European Journal of Clinical Pharmacology|January 1, 1984
Effect of diltiazem on plasma glucose, insulin and glucagon during an oral glucose tolerance test in healthy volunteersJ M Segrestaa, C Caulin, R Dahan, et al.Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1980
Evaluation of the absorption from some commercial sustained-release theophylline productsR A Upton, J F Thiercelin, T W Guentert, et al.European Journal of Clinical Pharmacology|January 1, 1996
Multiple dose pharmacokinetics of tiludronate in healthy volunteersH R Schwietert, P A Peeters, J Dingemanse, et al.European Journal of Clinical Pharmacology|January 1, 1989
Zolpidem excretion in breast milkG Pons, C Francoual, P Guillet, et al.Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1980
Evaluation of the absorption from some commercial enteric-release theophylline productsR A Upton, J R Powell, T W Guentert, et al.Fundamental & Clinical Pharmacology|December 18, 2004
Low levels of lymphocyte MDR1 gene expression during early renal transplantation in patients treated with tacrolimusL Becquemont, M Camus, F Kriaa, et al.Clinical Pharmacology and Therapeutics|September 1, 1995
Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humansC Partovian, E Jacqz-Aigrain, A Keundjian, et al.Pageof 17